Booklet for Hemato-Oncologists        

Case 12 (A, B) - Severe hypertension during the late intensification phase

Child, 9 years old, female, affected by SR-ALL. During the late intensification she developed severe (according to WHO criteria) hypertension. She was receiving the second dose of Vincristine and Doxorubicin. She completed the four doses of L-Asparaginase and was continuing with Dexamethasone (DXM).

» List of cases